120 related articles for article (PubMed ID: 2494631)
1. Src homology 2 domain deletion mutants of p60v-src do not phosphorylate cellular proteins of 120-150 kDa.
Wendler PA; Boschelli F
Oncogene; 1989 Feb; 4(2):231-6. PubMed ID: 2494631
[TBL] [Abstract][Full Text] [Related]
2. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
3. Localization of major potential substrates of p60v-src kinase in the plasma membrane matrix fraction.
Hamaguchi M; Hanafusa H
Oncogene Res; 1989; 4(1):29-37. PubMed ID: 2497423
[TBL] [Abstract][Full Text] [Related]
4. From c-src to v-src, or the case of the missing C terminus.
Sefton BM; Hunter T
Cancer Surv; 1986; 5(2):159-72. PubMed ID: 2430701
[TBL] [Abstract][Full Text] [Related]
5. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional motifs of the Rous sarcoma virus src protein.
Parsons JT; Wilkerson V; Parsons SJ
Gene Amplif Anal; 1986; 4():1-19. PubMed ID: 2851527
[TBL] [Abstract][Full Text] [Related]
7. Deletional analysis of the N-terminal half of the lyn gene.
Sasaki M
Kobe J Med Sci; 1990 Dec; 36(5-6):137-51. PubMed ID: 2087092
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src.
Hamaguchi M; Yamagata S; Thant AA; Xiao H; Iwata H; Mazaki T; Hanafusa H
Oncogene; 1995 Mar; 10(6):1037-43. PubMed ID: 7535415
[TBL] [Abstract][Full Text] [Related]
9. Correlation of V-src gene amplification with the tumorigenic phenotype in a Syrian hamster embryo cell line.
Gilmer TM; Lamb PW; Oshimura M; Barrett JC
Cancer Res; 1987 Sep; 47(17):4663-6. PubMed ID: 3040229
[TBL] [Abstract][Full Text] [Related]
10. Suppression of v-Src transformation in primary rat embryo fibroblasts.
Inoue H; Tavoloni N; Hanafusa H
Oncogene; 1995 Jul; 11(2):231-8. PubMed ID: 7624140
[TBL] [Abstract][Full Text] [Related]
11. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.
Kamps MP; Sefton BM
Oncogene; 1988 Apr; 2(4):305-15. PubMed ID: 2452398
[TBL] [Abstract][Full Text] [Related]
12. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
Barnes H; Ackermann EJ; van der Geer P
Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
[TBL] [Abstract][Full Text] [Related]
13. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
[TBL] [Abstract][Full Text] [Related]
14. A mutant form of the rho protein can restore stress fibers and adhesion plaques in v-src transformed fibroblasts.
Mayer T; Meyer M; Janning A; Schiedel AC; Barnekow A
Oncogene; 1999 Mar; 18(12):2117-28. PubMed ID: 10321736
[TBL] [Abstract][Full Text] [Related]
15. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
17. Product of the src gene is not phosphorylated in avian sarcoma virus B77 infected but untransformed human cells.
Altanerová V; Altaner C
Neoplasma; 1987; 34(4):409-16. PubMed ID: 2821417
[TBL] [Abstract][Full Text] [Related]
18. Src kinase tyrosine phosphorylates PTP1C, a protein tyrosine phosphatase containing Src homology-2 domains that down-regulates cell proliferation.
Matozaki T; Uchida T; Fujioka Y; Kasuga M
Biochem Biophys Res Commun; 1994 Oct; 204(2):874-81. PubMed ID: 7980555
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
